Cellebrite DI Ltd. (CLBT) has a consensus analyst rating of Buy, based on 8 analysts covering the stock. Of those, 8 recommend buying, 0 recommend holding, and 0 recommend selling.
The analyst consensus price target for CLBT is $20.67, representing a +74.3% upside from the current price of $11.86. Price targets range from a low of $18.00 to a high of $23.00.
